SEC Filing - Aura Biosciences, Inc. - Form 4

This filing reports a Form 4 filing for Aura Biosciences, Inc. (AURA) concerning transactions by Director Antony C. Mattessich. On June 11, 2026, Mattessich acquired 15,000 shares of Common Stock under a restricted stock unit (RSU) award from the Issuer's 2021 Stock Option and Incentive Plan. These RSUs vest fully on June 11, 2027, or the next annual meeting, contingent upon continued service. Additionally, a stock option for 30,000 shares of Common Stock was granted, also with full vesting on June 11, 2027, or the next annual meeting, subject to continued service. The option has an exercise price of $6.21 and expires on June 11, 2036. Post-transaction, Mattessich directly owns 38,500 shares of Common Stock and 30,000 shares underlying the option.